null

Streptococcus Agalactiae Group B Antibodies, Proteins & ELISA Kits

Streptococcus agalactiae (Group B Strep) Antibodies, Proteins & ELISA Kits | Assay Genie
Infectious Disease · Streptococcus agalactiae

Streptococcus agalactiae (Group B Strep) antibodies, proteins & ELISA kits

Streptococcus agalactiae (Group B Streptococcus, GBS) colonises the genital and gastrointestinal tract and is a leading cause of neonatal sepsis and meningitis.

Group B StrepCapsular antigensNeonatal risk
S. agalactiae
Group B Strep
Capsule
Serotype antigen
Perinatal
Mother-to-baby
Screening
Late pregnancy
Overview

What is Streptococcus agalactiae (Group B Strep)?

Streptococcus agalactiae (Group B Streptococcus, GBS) colonises the genital and gastrointestinal tract and is a leading cause of neonatal sepsis and meningitis.

Mother-to-baby transmission around birth drives perinatal screening. Antibody and antigen assays support GBS colonisation research, serotyping and maternal-vaccine development.

Transmission & symptoms

Streptococcus agalactiae (Group B Streptococcus, GBS) colonises the gastrointestinal and genital tracts and is a leading cause of neonatal sepsis, pneumonia and meningitis, acquired around the time of birth.

Diagnosis & serology

Maternal colonisation is detected by culture/PCR, and immunity research measures anti-capsular polysaccharide antibodies by serotype. ELISA supports maternal-vaccine immunogenicity studies.

Research applications

Research tools support GBS serotype and capsular-antibody research, complement-mediated killing and the maternal immune responses relevant to vaccine development.

FAQs

Streptococcus agalactiae (Group B Strep) — frequently asked questions

Why is Group B Strep screened for in pregnancy?
Because maternal GBS colonisation can be transmitted to the baby at birth and cause severe neonatal infection; intrapartum prophylaxis reduces this risk.
What is the basis of GBS vaccine research?
Capsular polysaccharide antigens (by serotype), often conjugated to carrier proteins, are the leading maternal-vaccine candidates.
How is GBS detected?
By culture or PCR of vaginal/rectal swabs in late pregnancy, with serological assays used in immunity and vaccine research.
Explore more

More Streptococcus agalactiae (Group B Strep) research tools

Need a Streptococcus agalactiae (Group B Strep) assay we don’t list?

Our PhD-level team can help you find the right kit, protein or antibody — or develop a custom assay for your target.

Talk to our team
Validated reagentsLinks checked & live7–10 day deliveryPhD-level support